多发性骨髓瘤的新疗法:益处和局限性
Artur Jurczyszyn1, Michał Bator2, Dav H Vesole3
1Plasma Cell Dyscrasias Center, Department of Hematology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland. mmjurczy@cyf-kr.edu.pl
新兴的分子向疗法,包括双特异性抗体和CAR T细胞,正在彻底改变多发性骨髓瘤 (MM) 治疗. 这些先进的免疫疗法为MM患者提供了改善的结果和生存率.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 多发性骨髓瘤 (MM) 是一种血细胞失分症,其特征是克隆增殖.
- 在过去的二十年中,显著的治疗进展改善了MM患者的治疗结果.
研究的目的:
- 为多发性骨髓瘤提供新兴分子向治疗方法的概述.
- 在MM治疗中突出两种特异性抗体和CAR T细胞疗法.
主要方法:
- 关于新型MM疗法的当前文献的综述.
- 对双特异抗体和CAR T细胞的临床试验结果的分析.
- 检查这些疗法的结构和功能方面.
主要成果:
- 引入免疫调节药物,单克隆抗体和蛋白酶体抑制剂改善了MM的预后.
- 双特异性抗体和CAR T细胞代表了MM的快速发展的免疫疗法方法.
- 关键考虑因素包括与治疗相关的毒性和管理策略.
结论:
- 分子向疗法,特别是双特异性抗体和CAR T细胞,正在改变MM治疗范式.
- 这些新型免疫疗法在改善MM患者的缓解时间和存活率方面具有显著的潜力.
- 有效管理与治疗相关的毒性对于成功实施至关重要.
更多相关视频
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Drug Therapy
Antianxiety Medications
